threewheeler Wednesday, 08/26/20 02:41:28 AM Re: None Post # of 9673 On August 11,2020 the Company issued 5,000,000 common shares to Kalos Therapeutics Inc. as a License Fee payment. https://investorshub.advfn.com/uimage/uploads/2020/4/16/prtfikb.jpg